Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes

Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes

Background Immune checkpoint inhibitors (ICPi) are a novel and promising anti-cancer therapy. There are limited data on the incidence, risk factors and outcomes of acute kidney injury (AKI) in patients receiving ICPi.Methods We conducted a cohort study of patients receiving ICPi at our center betwee...

Full description

Saved in:
Bibliographic Details
Main Authors: Eitan Amir, Joseph Kim, Christopher Chan, Alejandro Meraz-Muñoz, Pamela Ng, Carmen Avila-Casado, Claire Ragobar, Ron Wald, Abhijat Kitchlu
Format: Article
Language:English
Published: BMJ Publishing Group 2020-05-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/1/e000467.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items